Showing results (131-140 of 335) with videos related to
Sort By:
Pageof 34
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular CarcinomaKoen G A M Hussaarts, Leni van Doorn, Sander Bins, et al.The British Journal of Surgery|May 9, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysisNiels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert, et al.Pharmaceuticals (Basel, Switzerland)|January 13, 2021
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer PatientsLeni van Doorn, Marie-Rose B S Crombag, Hánah N Rier, et al.The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.Cancers|July 2, 2021
Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related PainBram C Agema, Astrid W Oosten, Sebastiaan D T Sassen, et al.Cancer Chemotherapy and Pharmacology|July 24, 2010
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis studyInge R H M Konings, Stefan Sleijfer, Ron H J Mathijssen, et al.Cancer Chemotherapy and Pharmacology|November 1, 2016
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal functionAnalía Azaro, Jordi Rodón, Jean-Pascal Machiels, et al.BMJ Neurology Open|August 5, 2026
Neurological complications induced by checkpoint inhibitors: characterising the clinical spectraAnne Merel van Wylick, Martin van den Bent, Bart C Jacobs, et al.Molecular Pharmacology|June 26, 2015
Lysosomal Sequestration Determines Intracellular Imatinib LevelsHerman Burger, Alexander T den Dekker, Sandra Segeletz, et al.British Journal of Clinical Pharmacology|June 30, 2015
4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanesAnne-Joy M de Graan, Alex Sparreboom, Peter de Bruijn, et al.Pageof 34